RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Jointown Pharmaceutical Group Co Stock

Jointown Pharmaceutical Group Co Net Income 2025

Jointown Pharmaceutical Group Co Net Income

2.68 B CNY

Ticker

600998.SS

ISIN

CNE100000W45

In 2025, Jointown Pharmaceutical Group Co's profit amounted to 2.68 B CNY, a 13.14% increase from the 2.36 B CNY profit recorded in the previous year.

The Jointown Pharmaceutical Group Co Net Income history

YEARNET INCOME (undefined CNY)
2026e3
2025e2.68
2024e2.36
20232.17
20222.07
20212.44
20202.96
20191.56
20181.12
20171.34
20160.82
20150.7
20140.56
20130.48
20120.41
20110.37
20100.36
20090.3
20080.2
20070.16

Jointown Pharmaceutical Group Co Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Jointown Pharmaceutical Group Co, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Jointown Pharmaceutical Group Co from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Jointown Pharmaceutical Group Co’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Jointown Pharmaceutical Group Co. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Jointown Pharmaceutical Group Co’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Jointown Pharmaceutical Group Co’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Jointown Pharmaceutical Group Co’s growth potential.

Jointown Pharmaceutical Group Co Revenue, EBIT and net profit per share

DateJointown Pharmaceutical Group Co RevenueJointown Pharmaceutical Group Co EBITJointown Pharmaceutical Group Co Net Income
2026e184.54 B undefined5.68 B undefined3 B undefined
2025e169.68 B undefined5.18 B undefined2.68 B undefined
2024e156.29 B undefined4.65 B undefined2.36 B undefined
2023150.14 B undefined4.16 B undefined2.17 B undefined
2022140.42 B undefined3.55 B undefined2.07 B undefined
2021122.41 B undefined3.19 B undefined2.44 B undefined
2020110.86 B undefined3.78 B undefined2.96 B undefined
201999.5 B undefined3.31 B undefined1.56 B undefined
201887.14 B undefined2.56 B undefined1.12 B undefined
201773.94 B undefined2.1 B undefined1.34 B undefined
201661.56 B undefined1.67 B undefined820 M undefined
201549.59 B undefined1.3 B undefined695 M undefined
201441.07 B undefined980 M undefined561 M undefined
201333.44 B undefined805 M undefined478 M undefined
201229.51 B undefined681 M undefined413 M undefined
201124.84 B undefined525 M undefined374 M undefined
201021.19 B undefined570 M undefined360 M undefined
200918.96 B undefined425 M undefined298 M undefined
200816.29 B undefined330 M undefined203 M undefined
200713.05 B undefined248 M undefined160 M undefined

Jointown Pharmaceutical Group Co stock margins

The Jointown Pharmaceutical Group Co margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Jointown Pharmaceutical Group Co. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Jointown Pharmaceutical Group Co.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Jointown Pharmaceutical Group Co's sales revenue. A higher gross margin percentage indicates that the Jointown Pharmaceutical Group Co retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Jointown Pharmaceutical Group Co's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Jointown Pharmaceutical Group Co's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Jointown Pharmaceutical Group Co's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Jointown Pharmaceutical Group Co. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Jointown Pharmaceutical Group Co's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Jointown Pharmaceutical Group Co Margin History

Jointown Pharmaceutical Group Co Gross marginJointown Pharmaceutical Group Co Profit marginJointown Pharmaceutical Group Co EBIT marginJointown Pharmaceutical Group Co Profit margin
2026e8.02 %3.08 %1.63 %
2025e8.02 %3.05 %1.58 %
2024e8.02 %2.97 %1.51 %
20238.02 %2.77 %1.45 %
20227.76 %2.53 %1.48 %
20218.01 %2.61 %1.99 %
20208.94 %3.41 %2.67 %
20198.73 %3.32 %1.57 %
20188.62 %2.94 %1.29 %
20178.43 %2.84 %1.81 %
20167.83 %2.71 %1.33 %
20157.54 %2.61 %1.4 %
20147.08 %2.39 %1.37 %
20136.65 %2.41 %1.43 %
20126.34 %2.31 %1.4 %
20115.89 %2.11 %1.51 %
20106.43 %2.69 %1.7 %
20095.93 %2.24 %1.57 %
20085.51 %2.03 %1.25 %
20074.95 %1.9 %1.23 %

Jointown Pharmaceutical Group Co Aktienanalyse

What does Jointown Pharmaceutical Group Co do?

Jointown Pharmaceutical Group Co Ltd is a Chinese company specializing in the production and distribution of pharmaceuticals. The company was founded in 1999 in Wuhan and has since become a significant player in the pharmaceutical industry. The company's business model is based on the production and sale of generic drugs, which are cheaper alternatives to existing medications. This makes them more affordable for many people. Jointown Pharmaceuticals operates in various areas, with one of the main areas being the production of cancer drugs. The company manufactures a variety of cancer medications and is one of the leading manufacturers in China in this field. Jointown Pharmaceuticals is also active in other areas of medicine, such as producing medications for diabetes, infectious diseases, and cardiovascular diseases. The company offers a wide range of products, including generics, patented medications, medical devices, diagnostics, dietary supplements, and cosmetic products. Jointown Pharmaceuticals emphasizes close collaboration with scientific institutions and partnerships with foreign partners in order to drive the development of new products and expand internationally. Jointown is also active in Germany through its subsidiary, Jointown Europe GmbH. The company's history is marked by steady growth. Jointown Pharmaceuticals has become one of the leading pharmaceutical companies in China within a few years and has gained international recognition. In 2013, the company successfully went public, generating additional financial resources. In addition to its pharmaceutical business, Jointown Pharmaceuticals is also involved in social projects. The company contributes to the fight against poverty and diseases in China and prioritizes environmental protection and sustainability. Overall, Jointown Pharmaceuticals is an innovative and successful company in the pharmaceutical industry. Its focus on the production of generics contributes significantly to providing affordable medications to the population. The wide range of products and the close collaboration with international partners demonstrate a modern and globally oriented corporate culture. Jointown Pharmaceutical Group Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Net Income Details

Understanding Jointown Pharmaceutical Group Co's Profit Margins

The profit margins of Jointown Pharmaceutical Group Co represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of Jointown Pharmaceutical Group Co's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.

Year-to-Year Comparison

Evaluating Jointown Pharmaceutical Group Co's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.

Impact on Investments

Jointown Pharmaceutical Group Co's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.

Interpreting Profit Fluctuations

When Jointown Pharmaceutical Group Co’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.

Frequently Asked Questions about Jointown Pharmaceutical Group Co stock

How much profit has Jointown Pharmaceutical Group Co made this year?

Jointown Pharmaceutical Group Co has made 2.68 B CNY this year.

How has the profit developed compared to last year?

The profit has increased by 13.14% compared to last year increased

What impact do the earnings have on the shareholders?

An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.

How does Jointown Pharmaceutical Group Co publish its earnings?

Jointown Pharmaceutical Group Co publishes its earnings in the form of quarterly or annual reports.

Which financial indicators are included in the quarterly or annual reports?

The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.

Why is it important for investors to know the earnings of Jointown Pharmaceutical Group Co?

The profits of Jointown Pharmaceutical Group Co are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.

How can one learn more about the earnings of Jointown Pharmaceutical Group Co?

You can learn more about the earnings of Jointown Pharmaceutical Group Co by reviewing the quarterly or annual reports or following the company presentations.

How much dividend does Jointown Pharmaceutical Group Co pay?

Over the past 12 months, Jointown Pharmaceutical Group Co paid a dividend of 0.24 CNY . This corresponds to a dividend yield of about 4.87 %. For the coming 12 months, Jointown Pharmaceutical Group Co is expected to pay a dividend of 0.24 CNY.

What is the dividend yield of Jointown Pharmaceutical Group Co?

The current dividend yield of Jointown Pharmaceutical Group Co is 4.87 %.

When does Jointown Pharmaceutical Group Co pay dividends?

Jointown Pharmaceutical Group Co pays a quarterly dividend. This is distributed in the months of July, July, July, July.

How secure is the dividend of Jointown Pharmaceutical Group Co?

Jointown Pharmaceutical Group Co paid dividends every year for the past 6 years.

What is the dividend of Jointown Pharmaceutical Group Co?

For the upcoming 12 months, dividends amounting to 0.24 CNY are expected. This corresponds to a dividend yield of 4.94 %.

In which sector is Jointown Pharmaceutical Group Co located?

Jointown Pharmaceutical Group Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Jointown Pharmaceutical Group Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Jointown Pharmaceutical Group Co from 6/7/2024 amounting to 0.194 CNY, you needed to have the stock in your portfolio before the ex-date on 6/7/2024.

When did Jointown Pharmaceutical Group Co pay the last dividend?

The last dividend was paid out on 6/7/2024.

What was the dividend of Jointown Pharmaceutical Group Co in the year 2024?

In the year 2024, Jointown Pharmaceutical Group Co distributed 0.24 CNY as dividends.

In which currency does Jointown Pharmaceutical Group Co pay out the dividend?

The dividends of Jointown Pharmaceutical Group Co are distributed in CNY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Jointown Pharmaceutical Group Co

Our stock analysis for Jointown Pharmaceutical Group Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Jointown Pharmaceutical Group Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.